Better Target Leede Jones Gable analyst Doug Loe, who focuses on healthcare and biotechnology, named a pair of TSX Venture Exchange-listed stocks as his top picks for the first quarter of the year.
His selections are:
* Quipt Home Medical Corp. with a “buy” rating and $14.50 target. Average: $12.63.
“The firm has sustained both organic and acquisitive growth in its U.S. respiratory therapy niche throughout our coverage history of the firm, invariably while preserving EBITDA and margin growth in the process,” said Mr. Loe. “Our forecasts and the firm’s own revenue/EBITDA run-rate guidance is consistent with the view that profitability trends should continue over the timeframe that our Top Pick designation applies. Our PT corresponds to a one-year return of 101 per cent.”